EPCRC发布首部癌症姑息治疗抑郁症管理指南

2011-03-25 MedSci原创 MedSci原创

  癌症患者在姑息治疗中发生抑郁很常见,为使临床医师有“据”可依地进行处理,欧洲姑息治疗研究协作组(EPCRC)在系统性回顾了现有循证医学证据并进行了德尔斐(Delphi)研究后,制定出欧洲第一部癌症姑息治疗抑郁症管理指南。相关内容参见《欧洲癌症杂志》 [Eur J Cancer 2011, 47(5): 702]。   姑息治疗中抑郁症的预

  癌症患者在姑息治疗中发生抑郁很常见,为使临床医师有“据”可依地进行处理,欧洲姑息治疗研究协作组(EPCRC)在系统性回顾了现有循证医学证据并进行了德尔斐(Delphi)研究后,制定出欧洲第一部癌症姑息治疗抑郁症管理指南。相关内容参见《欧洲癌症杂志》 [Eur J Cancer 2011, 47(5): 702]。

  姑息治疗中抑郁症的预防推荐

  推荐1:

  临床医师应以一种开放性、非审视性、以患者为中心的方式与患者交流,积极询问患者的顾虑和感受。

  证据级别:中 推荐级别:强

  推荐2:

  依照患者意愿,临床医师应提供关于其疾病性质、进程和治疗的信息,并给予适当的支持资料。

  证据级别:中推荐级别:强

  推荐3:

  临床医师应考虑向姑息治疗专家征询意见,以更好地控制患者症状和给予其社会心理方面的支持。

  证据级别:高推荐级别:强

  姑息治疗中抑郁症的筛查、诊断和严重性 评估推荐

  推荐4:

  在筛查抑郁症时,临床医师应优先以认知和(或)情感症状为主,因为某些躯体症状(例如体重下降和疲劳)是由躯体疾病或治疗导致的。

  证据级别:中推荐级别:强

  推荐5:

  临床医师应考虑在接受姑息治疗的患者中进行抑郁症筛查;

  筛查工具有助于抑郁症识别,但这些工具能否改善抑郁症转归尚不可知。

  证据级别:很低推荐级别:弱

  推荐6:

  接受癌症姑息治疗者的心理状态并不稳定,临床医师应对其抑郁症状进行周期性检查,以及时捕捉到患者的情绪变化。

  证据级别:中推荐级别:强

  姑息治疗中抑郁症的治疗推荐

  推荐7:

  临床医师应将抑郁症患者交予姑息治疗专家处理,以便更好地控制其症状和给予其社会心理方面的支持。

  证据级别:高推荐级别:强

  推荐8:

  对于接受姑息治疗的抑郁症患者,临床医师应考虑给予抗抑郁药物。

  证据级别:高推荐级别:强

  推荐9:

  对于接受姑息治疗的抑郁症患者,临床医师应考虑给予心理治疗。

  证据级别:高推荐级别:强

  北京肿瘤医院康复科唐丽丽教授点评:

  这部指南以表格形式简单明了地将姑息治疗中抑郁的筛查程序、识别方法及处理方式呈现给医师,简单实用,一目了然,非常适合临床医师在繁忙的临床工作中,快速发现抑郁的征兆及迹象,并进一步做出相应的鉴别和处理。该指南非常值得引入到肿瘤的姑息治疗实践中来,因为我们目前既缺少这样的理念,也缺少这样能进行快速筛查的方法。而若想提高接受姑息治疗患者的生活质量,就需要我们尽快发现患者存在的抑郁症状及精神痛苦,这些筛查方式的引入将有助于提高我国临床医师在姑息治疗中对抑郁症的认识并针对其进行积极处理。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1827222, encodeId=f7d7182e22207, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5194, encryptionId=52e95194b9, topicName=CRC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Wed Sep 14 19:49:00 CST 2011, time=2011-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023859, encodeId=9f9e202385940, content=<a href='/topic/show?id=99ff64628fb' target=_blank style='color:#2F92EE;'>#治疗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64628, encryptionId=99ff64628fb, topicName=治疗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5e185, createdName=zlawrance, createdTime=Tue Mar 29 19:49:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936243, encodeId=9a2819362437a, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Jul 28 11:49:00 CST 2011, time=2011-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419353, encodeId=2c87141935353, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537081, encodeId=a888153e0814d, content=<a href='/topic/show?id=9faa6856e9' target=_blank style='color:#2F92EE;'>#Epcr#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6856, encryptionId=9faa6856e9, topicName=Epcr)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0c12789666, createdName=ssnine, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626600, encodeId=54741626600f7, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=)]
    2011-09-14 yxch36
  2. [GetPortalCommentsPageByObjectIdResponse(id=1827222, encodeId=f7d7182e22207, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5194, encryptionId=52e95194b9, topicName=CRC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Wed Sep 14 19:49:00 CST 2011, time=2011-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023859, encodeId=9f9e202385940, content=<a href='/topic/show?id=99ff64628fb' target=_blank style='color:#2F92EE;'>#治疗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64628, encryptionId=99ff64628fb, topicName=治疗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5e185, createdName=zlawrance, createdTime=Tue Mar 29 19:49:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936243, encodeId=9a2819362437a, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Jul 28 11:49:00 CST 2011, time=2011-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419353, encodeId=2c87141935353, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537081, encodeId=a888153e0814d, content=<a href='/topic/show?id=9faa6856e9' target=_blank style='color:#2F92EE;'>#Epcr#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6856, encryptionId=9faa6856e9, topicName=Epcr)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0c12789666, createdName=ssnine, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626600, encodeId=54741626600f7, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1827222, encodeId=f7d7182e22207, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5194, encryptionId=52e95194b9, topicName=CRC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Wed Sep 14 19:49:00 CST 2011, time=2011-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023859, encodeId=9f9e202385940, content=<a href='/topic/show?id=99ff64628fb' target=_blank style='color:#2F92EE;'>#治疗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64628, encryptionId=99ff64628fb, topicName=治疗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5e185, createdName=zlawrance, createdTime=Tue Mar 29 19:49:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936243, encodeId=9a2819362437a, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Jul 28 11:49:00 CST 2011, time=2011-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419353, encodeId=2c87141935353, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537081, encodeId=a888153e0814d, content=<a href='/topic/show?id=9faa6856e9' target=_blank style='color:#2F92EE;'>#Epcr#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6856, encryptionId=9faa6856e9, topicName=Epcr)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0c12789666, createdName=ssnine, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626600, encodeId=54741626600f7, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1827222, encodeId=f7d7182e22207, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5194, encryptionId=52e95194b9, topicName=CRC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Wed Sep 14 19:49:00 CST 2011, time=2011-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023859, encodeId=9f9e202385940, content=<a href='/topic/show?id=99ff64628fb' target=_blank style='color:#2F92EE;'>#治疗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64628, encryptionId=99ff64628fb, topicName=治疗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5e185, createdName=zlawrance, createdTime=Tue Mar 29 19:49:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936243, encodeId=9a2819362437a, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Jul 28 11:49:00 CST 2011, time=2011-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419353, encodeId=2c87141935353, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537081, encodeId=a888153e0814d, content=<a href='/topic/show?id=9faa6856e9' target=_blank style='color:#2F92EE;'>#Epcr#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6856, encryptionId=9faa6856e9, topicName=Epcr)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0c12789666, createdName=ssnine, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626600, encodeId=54741626600f7, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=)]
    2011-03-27 Tommy1950
  5. [GetPortalCommentsPageByObjectIdResponse(id=1827222, encodeId=f7d7182e22207, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5194, encryptionId=52e95194b9, topicName=CRC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Wed Sep 14 19:49:00 CST 2011, time=2011-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023859, encodeId=9f9e202385940, content=<a href='/topic/show?id=99ff64628fb' target=_blank style='color:#2F92EE;'>#治疗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64628, encryptionId=99ff64628fb, topicName=治疗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5e185, createdName=zlawrance, createdTime=Tue Mar 29 19:49:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936243, encodeId=9a2819362437a, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Jul 28 11:49:00 CST 2011, time=2011-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419353, encodeId=2c87141935353, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537081, encodeId=a888153e0814d, content=<a href='/topic/show?id=9faa6856e9' target=_blank style='color:#2F92EE;'>#Epcr#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6856, encryptionId=9faa6856e9, topicName=Epcr)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0c12789666, createdName=ssnine, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626600, encodeId=54741626600f7, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=)]
    2011-03-27 ssnine
  6. [GetPortalCommentsPageByObjectIdResponse(id=1827222, encodeId=f7d7182e22207, content=<a href='/topic/show?id=52e95194b9' target=_blank style='color:#2F92EE;'>#CRC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5194, encryptionId=52e95194b9, topicName=CRC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Wed Sep 14 19:49:00 CST 2011, time=2011-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023859, encodeId=9f9e202385940, content=<a href='/topic/show?id=99ff64628fb' target=_blank style='color:#2F92EE;'>#治疗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64628, encryptionId=99ff64628fb, topicName=治疗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5e185, createdName=zlawrance, createdTime=Tue Mar 29 19:49:00 CST 2011, time=2011-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936243, encodeId=9a2819362437a, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Jul 28 11:49:00 CST 2011, time=2011-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419353, encodeId=2c87141935353, content=<a href='/topic/show?id=e290138682e' target=_blank style='color:#2F92EE;'>#PCR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13868, encryptionId=e290138682e, topicName=PCR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9cc43496966, createdName=Tommy1950, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537081, encodeId=a888153e0814d, content=<a href='/topic/show?id=9faa6856e9' target=_blank style='color:#2F92EE;'>#Epcr#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6856, encryptionId=9faa6856e9, topicName=Epcr)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0c12789666, createdName=ssnine, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1626600, encodeId=54741626600f7, content=<a href='/topic/show?id=2d91449540c' target=_blank style='color:#2F92EE;'>#姑息#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44954, encryptionId=2d91449540c, topicName=姑息)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adea21051784, createdName=经常头晕, createdTime=Sun Mar 27 13:49:00 CST 2011, time=2011-03-27, status=1, ipAttribution=)]

相关资讯

ASCO推荐2010年癌症临床53项进展

MedSci报道:刚刚,ASCO推荐2010年癌症临床53项进展,包括12项主要临床成就,如个性化医疗,靶向治疗,新治疗方案和手术方案,减少肿瘤复发,提高生活质量等。 从这篇报道中,我们能学习到肿瘤领域,全球最关注的是什么?整体发展动向是什么?过去更关心肿瘤化疗方案的改进,优化;关心肿瘤患者的生存期。而近年来焦点已明显转变,已从关注生存期,变化到关注生存质量,包括生存质量评估,无病生存,无进展生

新分子工具探讨癌细胞的生与死

在发展新的癌症治疗上不论是基础或转译研究上都集中在肿瘤细胞不同功能的作用上,其中一个领域是肿瘤细胞的生与死。细胞凋亡,也称作细胞计划性死亡,是细胞包括肿瘤细胞的一个基本作用,细胞凋亡的讯号诱导路径牵涉到很多不同蛋白质及其交互作用,在凋亡讯号中,蛋白质和蛋白质间的交互作用就像很多其他生物反应过程一样,通常由蛋白质交互作用的介面上,有重要的构造或功能上的一些片断或几个重要胺基酸序列来决定或影响其作用。